CN106236774A - A kind of Multi-purpose antibiotic agent - Google Patents
A kind of Multi-purpose antibiotic agent Download PDFInfo
- Publication number
- CN106236774A CN106236774A CN201610628176.0A CN201610628176A CN106236774A CN 106236774 A CN106236774 A CN 106236774A CN 201610628176 A CN201610628176 A CN 201610628176A CN 106236774 A CN106236774 A CN 106236774A
- Authority
- CN
- China
- Prior art keywords
- parts
- surfactant
- antibacterial
- alkylol
- antibiotic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to a kind of Multi-purpose antibiotic agent, including hydrogen peroxide, unsaturated carboxylic acid, sodium benzoate, alkylol, ether glycol, ammonium salt, hydrophobic components, surfactant, the mass fraction of each component is: hydrogen peroxide 1 2.5 parts, unsaturated carboxylic acid 0.5 2 parts, sodium benzoate 0.5 0.8 parts, alkylol 15 parts, ether glycol 25 parts, ammonium salt 35 parts, hydrophobic components 2.5 4 parts, 1.5 3 parts of surfactant.This antibacterial has the advantage such as good stability, usage amount bacterium low, antibacterial spectrum wide, high-efficiency antimicrobial, antibacterial effect persistent period length, is widely used in various daily life field and medical domain.
Description
Technical field
The present invention relates to a kind of antibacterial.Especially, the present invention relates to a kind of antimicrobial, antibacterial, antifungal, antiviral
Multi-purpose antibiotic agent.
Background technology
At present, clinical when treating various infective wound surface, the conventional treatments used is antibacterial, antiinflammatory, debridement.
External used medicine used over the course for the treatment of mostly is antibiosis anti-inflammatory drug.But there is certain weak point in these medicines.Such as clinic
The antibiotic medicines such as upper conventional tetracycline ointment, gentamycin sliver, nitrofural sliver, along with it is extensive and heavy dose of
Application, makes sensitive organism that it is produced corresponding Drug resistance, therefore unsatisfactory curative effect, adds antibiotics and only have antibacterial action,
The blood circulation of local organization and oozing out of suppression wound fluid can not be promoted, so, once there is Drug resistance in antibacterial, wound
The infection in face can deteriorate further, thus causes the disastrous effect of protracted course of disease.Though antibacterial is not likely to produce Drug resistance in the treatment, but
The effect of its antibacterial and anti-inflammation functions and promotion organization healing is the most weak, therefore the healing stage of wound is longer.Although natural prodcuts are pacified
Entirely, but typically expensive, broad-spectrum biological body such as Gram-negative and gram-positive bacterium and fungus are not had biocidal effect.
Summary of the invention
For above-mentioned deficiency present in prior art, the technical problem to be solved is to provide a kind of effective
Multi-purpose antibiotic agent.
The technical solution adopted for the present invention to solve the technical problems is: provide a kind of Multi-purpose antibiotic agent, including peroxide
Change hydrogen, unsaturated carboxylic acid, sodium benzoate, alkylol, ether glycol, ammonium salt, hydrophobic components, surfactant, the matter of each component
Amount number is: hydrogen peroxide 1-2.5 part, unsaturated carboxylic acid 0.5-2 part, sodium benzoate 0.5-0.8 part, alkylol 1-5 part, ether two
Alcohol 2-5 part, ammonium salt 3-5 part, hydrophobic components 2.5-4 part, surfactant 1.5-3 part.
As preferably, described Multi-purpose antibiotic agent, the mass fraction of each component is: hydrogen peroxide 1 part, unsaturated carboxylic acid
0.5 part, sodium benzoate 0.5 part, alkylol 1 part, ether glycol 2 parts, ammonium salt 3 parts, hydrophobic components 2.5 parts, surfactant 1.5
Part.
As preferably, described Multi-purpose antibiotic agent, described surfactant be sulfonate, sulfate surfactant,
Phosphonate surfactant, phosphate surfactant active, pool network sand nurse, cationic surfactant or its mixture.
As preferably, described Multi-purpose antibiotic agent, alkylol, ether glycol are the reinforcing agent component of this antibacterial,
The total concentration of enhancer component is relative to the total concentration of this antibacterial, by weight, in the range of 10:1 to 1:300.
As preferably, described Multi-purpose antibiotic agent, total relative to this antibacterial of the total concentration of contained enhancer component
Concentration, the most preferably in the range of 5:1 to 1:100.
This antibacterial has that good stability, usage amount bacterium low, antibacterial spectrum be wide, high-efficiency antimicrobial, the antibacterial effect persistent period
The advantages such as length, are widely used in various daily life field and medical domain.
Detailed description of the invention
The present invention provide a kind of Multi-purpose antibiotic agent, including hydrogen peroxide, unsaturated carboxylic acid, sodium benzoate, alkylol,
Ether glycol, ammonium salt, hydrophobic components, surfactant, the mass fraction of each component is: hydrogen peroxide 1-2.5 part, unsaturated carboxylic
Acid 0.5-2 part, sodium benzoate 0.5-0.8 part, alkylol 1-5 part, ether glycol 2-5 part, ammonium salt 3-5 part, hydrophobic components 2.5-4
Part, surfactant 1.5-3 part.
As preferably, described Multi-purpose antibiotic agent, the mass fraction of each component is: hydrogen peroxide 1 part, unsaturated carboxylic acid
0.5 part, sodium benzoate 0.5 part, alkylol 1 part, ether glycol 2 parts, ammonium salt 3 parts, hydrophobic components 2.5 parts, surfactant 1.5
Part.
As preferably, described Multi-purpose antibiotic agent, described surfactant be sulfonate, sulfate surfactant,
Phosphonate surfactant, phosphate surfactant active, pool network sand nurse, cationic surfactant or its mixture.
As preferably, described Multi-purpose antibiotic agent, alkylol, ether glycol are the reinforcing agent component of this antibacterial,
The total concentration of enhancer component is relative to the total concentration of this antibacterial, by weight, in the range of 10:1 to 1:300.
As preferably, described Multi-purpose antibiotic agent, total relative to this antibacterial of the total concentration of contained enhancer component
Concentration, the most preferably in the range of 5:1 to 1:100.
The above, be only to presently preferred embodiments of the present invention, the present invention not do the restriction of other forms, appoints
What those skilled in the art changed possibly also with the technology contents of the disclosure above or be modified as changing on an equal basis etc.
Effect embodiment.Every without departing from the present invention program content, the technical spirit of the foundation present invention is to made for any of the above embodiments any
Simple modification, equivalent variations and remodeling, all fall within protection scope of the present invention.
Claims (5)
1. a Multi-purpose antibiotic agent, including hydrogen peroxide, unsaturated carboxylic acid, sodium benzoate, alkylol, ether glycol, ammonium salt, dredges
Aqueous components, surfactant, the mass fraction of each component is: hydrogen peroxide 1-2.5 part, unsaturated carboxylic acid 0.5-2 part, benzene first
Acid sodium 0.5-0.8 part, alkylol 1-5 part, ether glycol 2-5 part, ammonium salt 3-5 part, hydrophobic components 2.5-4 part, surfactant
1.5-3 part.
Multi-purpose antibiotic agent the most according to claim 1, the mass fraction of each component is: hydrogen peroxide 1 part, unsaturated carboxylic
Acid 0.5 part, sodium benzoate 0.5 part, alkylol 1 part, ether glycol 2 parts, ammonium salt 3 parts, hydrophobic components 2.5 parts, surfactant
1.5 part.
3., according to the Multi-purpose antibiotic agent described in claim 1-2, described surfactant is sulfonate, sulfate surface activity
Agent, phosphonate surfactant, phosphate surfactant active, pool network sand nurse, cationic surfactant or its mixture.
Multi-purpose antibiotic agent the most according to claim 1, alkylol, ether glycol are the reinforcing agent component of this antibacterial,
The total concentration of enhancer component is relative to the total concentration of this antibacterial, by weight, in the range of 10:1 to 1:300.
Multi-purpose antibiotic agent the most according to claim 4, the total concentration of contained enhancer component is relative to this antibacterial
Total concentration, the most preferably in the range of 5:1 to 1:100.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610628176.0A CN106236774A (en) | 2016-08-04 | 2016-08-04 | A kind of Multi-purpose antibiotic agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610628176.0A CN106236774A (en) | 2016-08-04 | 2016-08-04 | A kind of Multi-purpose antibiotic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106236774A true CN106236774A (en) | 2016-12-21 |
Family
ID=57607274
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610628176.0A Pending CN106236774A (en) | 2016-08-04 | 2016-08-04 | A kind of Multi-purpose antibiotic agent |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106236774A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107095901A (en) * | 2017-05-25 | 2017-08-29 | 周淑华 | A kind of antibacterial agent |
CN107279187A (en) * | 2017-05-25 | 2017-10-24 | 周淑华 | A kind of Multi-purpose antibiotic agent |
CN107279194A (en) * | 2017-05-30 | 2017-10-24 | 花舜 | A kind of draft antiseptic |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993015018A1 (en) * | 1992-01-24 | 1993-08-05 | John Petchul | Process and composition for microemulsion gel having bleaching and antiseptic properties |
CN101048064A (en) * | 2004-09-07 | 2007-10-03 | 3M创新有限公司 | Antiseptic compositions and methods of use |
CN101137343A (en) * | 2005-03-10 | 2008-03-05 | 3M创新有限公司 | Antimicrobial film-forming dental compositions and methods |
CN101175474A (en) * | 2005-03-10 | 2008-05-07 | 3M创新有限公司 | Methods of reducing microbial contamination |
-
2016
- 2016-08-04 CN CN201610628176.0A patent/CN106236774A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993015018A1 (en) * | 1992-01-24 | 1993-08-05 | John Petchul | Process and composition for microemulsion gel having bleaching and antiseptic properties |
CN101048064A (en) * | 2004-09-07 | 2007-10-03 | 3M创新有限公司 | Antiseptic compositions and methods of use |
CN102908362A (en) * | 2004-09-07 | 2013-02-06 | 3M创新有限公司 | Antiseptic compositions and methods of use |
CN101137343A (en) * | 2005-03-10 | 2008-03-05 | 3M创新有限公司 | Antimicrobial film-forming dental compositions and methods |
CN101175474A (en) * | 2005-03-10 | 2008-05-07 | 3M创新有限公司 | Methods of reducing microbial contamination |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107095901A (en) * | 2017-05-25 | 2017-08-29 | 周淑华 | A kind of antibacterial agent |
CN107279187A (en) * | 2017-05-25 | 2017-10-24 | 周淑华 | A kind of Multi-purpose antibiotic agent |
CN107279194A (en) * | 2017-05-30 | 2017-10-24 | 花舜 | A kind of draft antiseptic |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Talapko et al. | Antibacterial activity of silver and its application in dentistry, cardiology and dermatology | |
AU2013299182B2 (en) | Physical antimicrobial method | |
Najjar et al. | Prophylactic antibiotics and prevention of surgical site infections | |
Pea et al. | Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability | |
Butcher | PHMB: an effective antimicrobial in wound bioburden management | |
CN106236774A (en) | A kind of Multi-purpose antibiotic agent | |
BR112018016341A2 (en) | catheter block solution and catheter block therapy | |
CN101380447A (en) | Chitose foaming agent for treating gynecologic disease and preparation method thereof | |
BR112022002156A2 (en) | Pharmaceutical composition for the treatment of African swine fever and its use | |
WO2009036714A1 (en) | Composition for the treatment of wounds, containing at least silver and urea | |
CN107279194A (en) | A kind of draft antiseptic | |
CN106344605A (en) | Novel antibacterial agent | |
Harris et al. | Eosinophilic pustular folliculitis in an HIV‐positive man: response to cetirizine | |
CN106177354A (en) | A kind of draft antibacterial | |
CN107279187A (en) | A kind of Multi-purpose antibiotic agent | |
CN106237335A (en) | A kind of dermatological field antibacterial | |
CN107095901A (en) | A kind of antibacterial agent | |
CN107115356A (en) | A kind of dermatological field antiseptic | |
CN106176863A (en) | A kind of medical antibacterial agent | |
CN107213315A (en) | A kind of antibacterial agent | |
Shorr et al. | Sepsis and septic shock: evolving evidence, evolving paradigms | |
CN105726564A (en) | Ointment for treating skin tinea | |
CN103110572A (en) | Gynecological antimicrobial gel recipe and preparation method thereof | |
CN107260930A (en) | A kind of draft antiseptic | |
Sabracos et al. | The in vitro effective antiviral action of povidone–iodine (PVP–I) may also have therapeutic potential by its intravenous administration diluted with Ringer’s solution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20161221 |